Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. (Q44044782)
Jump to navigation
Jump to search
scientific article published in July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. |
scientific article published in July 2002 |
Statements
1 reference
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. (English)
1 reference
J H Beijnen
1 reference
C M F Kruijtzer
1 reference
H Rosing
1 reference
W W ten Bokkel Huinink
1 reference
M Schot
1 reference
R C Jewell
1 reference
E M Paul
1 reference
J H M Schellens
1 reference
1 July 2002
1 reference
1 reference
20
1 reference
13
1 reference
2943-2950
1 reference
Identifiers
1 reference
1 reference